Xu Li
Senior Vice President of Clinical Development
Pharmaceuticals
Abbisko Therapeutics
China
Biography
Dr. Xu Li has more than 20 years of experience in clinical research and development of cancer. She guides / participates in global clinical research for multiple antineoplastic drugs. Dr. Xu Li served as vice president of Hengrui Pharmaceutical, responsible for Hengrui anti-tumor drug clinical research and development. Previously served as adviser to the Chinese Drug Administration Board of Drugs. Prior to returning to China, Dr. Xu was the Vice President of Pfizer's Cancer Division, the Director of Merck Global Medicine, the Senior Director of Immunomedics Clinical Affairs and the Director of PRA International Medical Medicine. Prior to joining the pharmaceutical industry, she completed postdoctoral training at the Memorial Sloan-Kettering Cancer Center in New York, USA,
Research Interest
Business, Management, Finance, Pharmaceuticals, Chemistry, Pharmacology
